Израел - иврит - Ministry of Health

novartis israel ltd - dexamethasone; neomycin as sulfate; polymyxin b sulfate - תרחיף לעין - dexamethasone 1.0 mg/ml; neomycin as sulfate 3,500 iu/ml; polymyxin b sulfate 6000 iu/ml - polymyxin b - polymyxin b - maxitrol is indicated in ocular inflammation when concurrent use of antimicrobial in judged necessary.

Израел - иврит - Ministry of Health

comex ltd., israel - dexamethasone sodium phosphate - תמיסה להזרקה - dexamethasone sodium phosphate 2 mg/ml

Израел - иврит - Ministry of Health

taro international ltd, israel - dexamethasone; levofloxacin - טיפות עיניים - levofloxacin 5 mg / 1 ml; dexamethasone 1 mg / 1 ml - dexamethasone and antiinfectives

Израел - иврит - Ministry of Health

teva pharmaceutical indust.ltd - dexamethasone sodium phosphate 20 mg/ml - solution for injection - dexamethasone - intravenous use as adjunctive treatment of severe shock of hemorrhagic, traumatic, surgical or septic origin.

Израел - иврит - Ministry of Health

lapidot medical import and marketing ltd - dexamethasone 1 mg/ml - suspension - dexamethasone - steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva cornea and anterior segment of the globe suppressing the reaction on transplant in keratoplasty.

Израел - иврит - Ministry of Health

m.p.vet ltd - dexamethasone as sodium phosphate - תמיסה להזרקה - dexamethasone as sodium phosphate 2 mg/ml

Израел - иврит - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole; dexamethasone acetate; neomycin sulfate - קרם - clotrimazole 1 %; neomycin sulfate 0.645 %; dexamethasone acetate 0.044 % - combinations - combinations - treatment of dermatitis involving also a bacterial and/or fungal infection.

Израел - иврит - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Израел - иврит - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Израел - иврит - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 10 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.